A Retrospective Analysis of R-MPV Plus Response-adapted Whole-brain Radiotherapy for Elderly Patients with Primary Central Nervous System Lymphoma

OBJECTIVE: Few reports have described the real-world outcomes of rituximab, methotrexate (MTX), procarbazine, and vincristine (R-MPV) plus response-adapted whole-brain radiotherapy (WBRT) for elderly patients with primary central nervous system lymphoma (PCNSL). We evaluated the outcome of this regi...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Yutaro, Imoto, Naoto, Ishihara, Shunichi, Fujiwara, Shinji, Ito, Rie, Sakai, Toshiyasu, Yamamoto, Satomi, Sugiura, Isamu, Kurahashi, Shingo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152862/
https://www.ncbi.nlm.nih.gov/pubmed/34670884
http://dx.doi.org/10.2169/internalmedicine.7805-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152862/
https://www.ncbi.nlm.nih.gov/pubmed/34670884
http://dx.doi.org/10.2169/internalmedicine.7805-21

Ejemplares similares